ASH/X
May 1, 2025, 14:00
ASH Highlights Role of Mass Spectrometry in Diagnosing MGTS
The American Society of Hematology (ASH) shared on X about a recent paper by David Murray and Anand Padmanabhan published in ASH Publications:
“Mass spectrometry is revealing critical insights into monoclonal gammopathy of thrombotic significance (MGTS), offering a new pathway for diagnosis and treatment. This groundbreaking approach could change the way we tackle diseases driven by antibodies.”
Authors: David Murray and Anand Padmanabhan
Read full article here.
In this update, ASH emphasized the emerging importance of mass spectrometry in understanding and managing monoclonal gammopathy of thrombotic significance (MGTS). By offering precise molecular insight into antibody-driven disorders, this approach has the potential to improve diagnosis and enable more targeted therapies. The announcement signals a new frontier in hematologic diagnostics and patient care.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 29, 2025, 22:38
May 29, 2025, 22:26